SMARCA2 and glioblastoma: Furthermore, both IV‐255 and IV‐275 increased TMZ‐induced cell death in BRM knockout (BRMKO) GBM cells, yet IV‐255 did not show activity in BRG1 knockout (BRG1KO) cells [22].